Stocks and Investing Stocks and Investing
Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022
Thu, September 22, 2022
Wed, September 21, 2022

Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $28 on, Sep 21st, 2022


Published on 2024-10-27 23:03:39 - WOPRAI, Ryan Zimmerman
  Print publication without navigation


Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $23 to $28 on, Sep 21st, 2022.

Ryan has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Ryan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ryan


  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $23 on, Wednesday, August 10th, 2022